The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: Development of novel prophylactic and therapeutic agents

Critical Reviews in Biochemistry and Molecular Biology

Volumn 37, Issue 5, 2002, Pages 339-373

  Jedrzejas, Mark J ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Anthrax; Bioterrorism; Clostridium; Drug; Threat agent; Vaccine

Indexed keywords

ADENYLATE CYCLASE; ANTHRAX TOXIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; EDEMA FACTOR; HEMOLYSIN; LETHAL FACTOR PROTEIN; METALLOPROTEINASE; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; PHOSPHOGLYCERATE MUTASE; PROTECTIVE ANTIGEN; PROTEINASE; RECOMBINANT ANTIBODY; SYNTHETASE; UNCLASSIFIED DRUG; BACTERIAL TOXIN; CARRIER PROTEIN; EDEMA FACTOR, BACTERIAL;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL SPORE; BIOLOGICAL WARFARE; CATALYSIS; DNA DAMAGE; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SPORE GERMINATION; STRUCTURE ANALYSIS; ANIMAL; CLOSTRIDIUM; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALIA; ANTHRAX; BACILLI; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; POSIBACTERIA;

ADENYLATE CYCLASE; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CARRIER PROTEINS; CLOSTRIDIUM; DNA DAMAGE; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036428851     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.1080/10409230290771537     Document Type: Review

References (128)

1. Albertini, A. M. and Galizzi, A. 1975. Mutant of Bacillus subtilis with a temperature-sensitive lesion in ribonucleic acid synthesis during germination. J. Bacteriol. 124:14-25.
2. Albertini, A. M. and Galizzi, A. 1990. The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like gene. J. Bacteriol. 172:5482-5485.
3. Albertini, A. M., Caramori, T., Henner, D., Ferrari, E., and Galizzi, A. 1987. Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J. Bacteriol. 169:1480-1484.
4. Albertini, A. M., Caramori, T., Scoffone, F., and Galizzi, A. 1988. The outB gene of Bacillus subtilis regulates its own transcription. Genes Dev. 2:1381-1388.
5. Antelmann, H., Schmid R., and Hecker, M. 1997. The NAD synthetase NadE (OutB) of Bacillus subtilis is a sigma B-dependent general stress protein. FEMS Microbiol. Lett. 153:405-409.
6. Arora, N. and Leppla, S. H. 1994. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect. Immun. 62:4955-4961.
7. Bernstein, H. J. 2000. Recent changes to RasMol, recombining the variants. Trends Biochem. Sci. 25:453-455.
8. Blanchet, C., Geourjon, C., and Deleage, G. 1997. Multiple Protein Sequence Analysis. IBCP, CNRS UPR 412, Lyon, France.
9. Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., and Young, J. A. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
10. 180-labeled substrate, investigations of the phosphatase and phosphoryl transfer activities, and evidence for a phosphoryl-enzyme intermediate. Biochemistry 16:3054-3060.
11. Brookmeyer, R. and Blades, N. 2002 Prevention of inhalational anthrax in the U.S. outbreak. Science 295:1861.
12. Brookmeyer, R., Blades, N., Hughes-Jones, M., and Henderson, D. 2001. The statistical analysis of truncated data: Application to the Sverdlovsk anthrax outbreak. Biostatistics 2:233-247.
13. Brossier, F. and Mock, M. 2001. Toxins of Bacillus anthracis. Toxicon 39:1747-1755.
14. Cano, R. J. and Borucki, M. K. 1995. Revival and identification of bacterial spores in 25-to 40-million-year-old Dominican amber. Science 268:1060-1064.
15. Carrillo-Martinez, Y. and Setlow, P. 1994. Properties of Bacillus subtilis small, acid-soluble spore proteins with changes in the sequence recognized by their specific protease. J. Bacteriol. 176:5357-5363.
16. Carson, M. 1997. Ribbons. Methods Enzymol. 277:493-505.
17. 2+ and is pH sensitive. Can. J. Microbiol. 44:759-767.
18. Chander, M., Setlow, P., Lamani, E., and Jedrzejas, M. J. 1999. Structural studies on a 2,3-diphosphoglycerate independent phosphoglycerate mutase from Bacillus stearothermophilus. J. Struct. Biol. 126:156-165.
19. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucl. Acids Res. 16:10881-10890.
20. + synthetase from Bacillus subtilis. Acta Crystallogr. D Biol. Crystallogr. 57:806-812.
21. Dickeson, S. K. and Santoro, S. A. 1998. Ligand recognition by the I domain-containing integrins. Cell Mol. Life Sci. 54:556-566.
22. Dixon, T. C., Meselson, M., Guillemin, J., and Hanna, P. C. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
23. Drum, C. L., Shen, Y., Rice, P. A., Bohm, A., and Tang, W. J. 2001. Crystallization and preliminary X-ray study of the edema factor exotoxin adenylyl cyclase domain from Bacillus anthracis in the presence of its activator, calmodulin. Acta Crystallogr. D Biol. Crystallogr. 57:1881-1884.
24. Drum, C. L., Yan, S. Z., Bard, J., Shen, Y. Q., Lu, D., Soelaiman, S., Grabarek, Z., Bohm, A., and Tang, W. J. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396-402.
25. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., and Vande Woude, G. F. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
26. Escuyer, V. and Collier, R. J. 1991. Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infect. Immun. 59:3381-3386.
27. Escuyer, V., Duflot, E., Sezer, O., Danchin, A., and Mock, M. 1988. Structural homology between virulence-associated bacterial adenylate cyclases. Gene 71:293-298.
28. Ezzell, J. W., Jr. and Abshire, T. G. 1988. Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect. Immun. 56:349-356.
29. Foster, J. W. and Moat, A. G. 1980. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol. Rev. 44:83-105.
30. Fothergill-Gilmore, L. A. and Michels, P. A. M. 1993. Evolution of glycolysis. Progr. Biophys. Mol. Biol. 59:105-235.
31. Fothergill-Gilmore, L. A. and Watson, H. C. 1989. The phosphoglycerate mutases. Adv. Enzymol. 62:227-313.
32. Friedlander, A. M., Bhatnagar, R., Leppla, S. H., Johnson, L., and Singh, Y. 1993. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61:245-252.
33. Galperin, M. Y. and Jedrzejas, M. J. 2001. Conserved core structure and active site residues in alkaline phosphatase superfamily enzymes. Proteins: Struct. Funct. Genet. 45:318-324.
34. Geoffroy, C., Gaillard, J. L., Alouf, J. E., and Berche, P. 1987. Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect. Immun. 55:1641-1646.
35. Grana, X., Perez de la Ossa, P., Broceno, C., Stocker, M., Garriga, J., Pigdomench, P., and Climent, F. 1995. 2,3-Bisphosphoglycerate-independent phosphoglycerate mutase is conserved among different phylogenetic kingdoms. Comp. Biochem. Physiol. 112B:287-293.
36. Guidi-Rontani, C. 2002. The alveolar macrophage: The Trojan horse of Bacillus anthracis. Trends Microbiol. 10:405-409.
37. Guidi-Rontani, C., Pereira, Y., Ruffie, S., Sirard, J. C., Weber-Levy, M., and Mock, M. 1999. Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol. Microbiol. 33:407-414.
38. Guidi-Rontani, C., Weber-Levy, M., Mock, M., and Cabiaux, V. 2000. Translocation of Bacillus anthracis lethal and edema factors across endosome membranes. Cell Microbiol. 2:259-264.
39. Gupta, P., Singh, A., Chauhan, V., and Bhatnagar, R. 2001. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis. Biochem. Biophys. Res. Commun. 280:158-163.
40. Hanna, P. 1998. Anthrax pathogenesis and host response. Curr. Top. Microbiol. 225:13-35.
41. Hanna, P. C. and Ireland, J. A. 1999. Understanding Bacillus anthracis pathogenesis. Trends Microbiol. 7:180-182.
42. Illades-Aguiar, B. and Setlow, P. 1994a. Autoprocessing of the protease that degrades small, acid-soluble proteins of spores of Bacillus species is triggered by low pH, dehydration, and dipicolinic acid. J. Bacteriol. 176:7032-7037.
43. Illades-Aguiar, B. and Setlow, P. 1994b. Studies of the processing of the protease which initiates degradation of small, acid-soluble proteins during germination of spores of Bacillus species. J. Bacteriol. 176:2788-2795.
44. Ivins, B. E. and Welkos, S. L. 1988. Recent advances in the development of an improved, human anthrax vaccine. Eur. J. Epidemiol. 4:12-19.
45. Ivins, B. E., Welkos, S. L., Little, S. F., Crumrine, M. H., and Nelson, G. O. 1992. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect. Immun. 60:662-668.
46. Jedrzejas, M. J. 2000. Structure, function, and evolution of phosphoglycerate mutases: Comparison with fructose-2,6-bisphosphatase, acid phosphatase, and alkaline phosphatase. Prog. Biophys. Mol. Biol. 73:263-287.
47. Jedrzejas, M. J. and Setlow, P. 2001. Comparison of the binuclear metalloenzymes diphosphoglycerate-independent phosphoglycerate mutase and alkaline phosphatase: Their mechanism of catalysis via a phosphoserine intermediate. Chem. Rev. 101:607-618.
48. Jedrzejas, M. J., Chandler, M., Setlow, P., and Krishnasamy, G. 2000a. Mechanism of catalysis of the cofactor independent phosphoglycerate mutase from Bacillus stearothermophilus: Crystal structure of the complex with 2-phosphoglycerate. J. Biol. Chem. 275:23146-23153.
49. Jedrzejas, M. J., Chandler, M., Setlow, P., and Krishnasamy, G. 2000b. Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus. EMBO J. 19:1419-1431.
50. Keim, P, Kalif, A., Schupp, J., Hill, K., Travis, S. E., Richmond, K., Adair, D. M., Hugh-Jones, M., Kuske, C. R., and Jackson, P. 1997. Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J. Bacteriol. 179:818-824.
51. Kelly, S. J. and Jedrzejas, M. J. 2000b. Crystallization and preliminary X-ray diffraction analysis of a functional form of pneumolysin, a virulence factor from Streptococcus pneumoniae. Acta Crystallogr. D Biol. Crystallogr. 56:1452-1455.
52. Kelly, S. J. and Jedrzejas, M. J. 2000a. Structure and molecular mechanism of a functional form of pneumolysin: A cholesterol-dependent cytolysin from Streptococcus pneumoniae. J. Struct. Biol. 132:72-81.
53. Kennedy, M. J., Reader, S. L., and Skwierczynski, L. M. 1994. Preservation records of microorganisms: Evidence of the tenacity of life. Microbiology 140:2513-2529.
54. Keynan, P. H., and Sandler, N. 1983. In: The Bacterial Spore, Vol. 2, pp. 1-48, Hurst, A., and Gould, G. W., Eds., Academic Press, London
55. Klimpel, K. R., Arora, N., and Leppla, S. H. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
56. Kuhn, N. J., Setlow, B., and Setlow, P. 1993. Manganese(II) activation of 3-phosphoglycerate mutase of Bacillus megaterium: pH-sensitive interconversion of active and inactive forms. Arch. Biochem. Biophys. 306:342-349.
57. Kuhn, N. J., Setlow, B., Setlow, P., Cammack, R., and Williams, R. 1995. Cooperative manganese(II) activation of 3-phosphoglycerate mutase of Bacillus megaterium: A biological pH-sensing mechanism in bacterial spore formation and germination. Arch. Biochem. Biophys. 320:35-42.
58. Labruyere, E., Kochi, S., and Mock, M. 1994. Functional analysis of the NH2-terminal region of Bacillus anthracis edema factor. In: Bacterial Protein Toxins, Vol. 73, pp. 3163-3166. Freer, J., Aitken, R., Alouf, J. E., Boulmains, G. et al. Eds., FEMS Symposium, Gustav Fisher, Stuttgart.
59. Labruyere, E., Mock, M., Surewicz, W. K., Mantsch, H. H., Rose, T., Munier, H., Sarfati, R. S., and Barzu, O. 1991. Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry 30:2619-2624.
60. LaForce, F. M. 1994. Anthrax. Clin. Infect. Dis. 19:1009-1013.
61. Lalitha, M. K. and Thomas, M. K. 1997. Penicillin resistance in Bacillus anthracis. Lancet 349:1522-1522.
62. Leppla, S. H. 1982. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 79:3162-3166.
63. Leppla, S. H. 1995. In: Bacterial Toxins and Virulence Factors in Disease, pp. 543-572, Moss, J., Iglewski, B., Vaughan, M., and Tu, A. T., Eds., Marcel Dekker, New York.
64. Lindahl, T. 1993. Instability and decay of the primary structure of DNA. Nature 362:709-715.
65. Little, S. F., Leppla, S. H., Burnett, J. W., and Friedlander, A. M. 1994. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies. Biochem. Biophys. Res. Commun. 199:676-682.
66. Loshon, C. A. and Setlow, P. 1982. Bacillus megaterium spore protease: Purification, radioimmunoassay, and analysis of antigen level and localization during growth, sporulation, and spore germination. J. Bacteriol. 150:303-311.
67. Loshon, C. A., Swerdlow, B. M., and Setlow, P. 1982. Bacillus megaterium spore protease: Synthesis and processing of precursor forms during sporulation and germination. J. Biol. Chem. 257:10838-10845.
68. Magill, N. G., Cowan, A. E., Leyva-Vasquez, M. A., Brown, M., Koppel, D. E., and Setlow, P. 1996. Analysis of the relationship between the decrease in pH and accumulation of 3-phosphoglyceric acid in developing forespore of Bacillus species. J. Bacteriol. 178:2204-2210.
69. Maynard, J. A., Maassen, C. B., Leppla, S. H., Brasky, K., Patterson, J. L., Iverson, B. L., and Georgiou, G. 2002. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 20:597-601.
70. Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., and Yampolskaya, O. 1994. The Sverdlovsk anthrax outbreak of 1979. Science 266:1202-1208.
71. Milne, J. C., Furlong, D., Hanna, P. C., Wall, J. S., and Collier, R. J. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-20612.
72. Mock, M. and Fouet, A. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
73. Molloy, S. S., Anderson, E. D., Jean, F., and Thomas, G. 1999. Bi-cycling the furin pathway: From TGN localization to pathogen activation and embryogenesis. Trends Cell. Biol. 9:28-35.
74. Mourez, M., Kane, R. S., Mogridge, J., Metallo, S., Deschatelets, P., Sellman, B. R., Whitesides, G. M., and Collier, R. J. 2001. Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19:958-961.
75. Mourez, M. and Lacy, D. B., Cunningham, K., Legmann, R., Sellman, B. R., Mogridge, J., and Collier, R. J. 2002. 2001: A year of major advances in anthrax toxin research. Trends Microbiol. 10:287-293.
76. Munier, H., Bouhss, A., Krin, E., Danchin, A., Gilles, A. M., Glaser, P., and Barzu, O. 1992. The role of histidine 63 in the catalytic mechanism of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 267:9816-9820.
77. Nessi, C., Albertini, A. M., Speranza, M. L., and Galizzi, A. 1995. The outB gene of Bacillus subtilis codes for NAD synthetase. J. Biol. Chem. 270:6181-6185.
78. Nessi, C., Jedrzejas, M. J., and Setlow, P. 1998. Structure and mechanism of action of the protease that degrades small, acid-soluble spore proteins during germination of spores of Bacillus species. J. Bacteriol. 180:5077-5084.
79. Nicholls, A., Sharp, K. A., and Honig, B. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:281-296.
80. Novak, J. M., Stein, M. P., Little, S. F., Leppla, S. H., and Friedlander, A. M. 1992. Functional characterization of protease-treated Bacillus anthracis protective antigen. J. Biol. Chem. 267:17186-17193.
81. Okinaka, R. T., Cloud, K., Hampton, O., Hoffmaster, A. R., Hill, K. K., Keim, P., Koehler, T. M., Lamke, G., Kumano, S., Mahillon, J., Manter, D., Martinez, Y., Ricke, D., Svensson, R., and Jackson, P. J. 1999. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J. Bacteriol. 181:6509-6515.
82. Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J., Lacy, D. B., Collier, R. J., Park, S., Leppla, S. H., Hanna, P., and Liddington, R. C. 2001. Crystal structure of the anthrax lethal factor. Nature 414:229-233.
83. Parker, M. W., Buckley, J. T., Postma, J. P., Tucker, A. D., Leonard, K., Pattus, F., and Tsernoglou, D. 1994. Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature 367:292-295.
84. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 462:199-204.
85. Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H., and Liddington, R. C. 1997. Crystal structure of the anthrax toxin protective antigen. Nature 385:833-838.
86. Ponnuraj, K., Nessi, C., Setlow, P., and Jedrzejas, M. J. 1999. Structural studies of a novel germination protease from spores of Bacillus megaterium. J. Struct. Biol. 125:19-24.
87. Ponnuraj, K., Rowland, S., Nessi, C., Setlow, P., and Jedrzejas, M. J. 2000. Crystal structure of a novel germination protease from spores of Bacillus megaterium: Structural arrangement and zymogen activation. J. Mol. Biol. 300:1-10.
88. Quinn, C. P., Singh, Y., Klimpel, K. R., and Leppla, S. H. 1991. Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J. Biol. Chem. 266:20124-20130.
89. Rigden, D. J., Mello, L. V., Setlow, P., and Jedrzejas, M.J. 2002a. Structure and mechanism of action of a cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus with broad specificity phosphatase activity. J. Mol. Biol. 315:1129-1143.
90. Rigden, D. J. Setlow, P. Setlow, B. Stein, R. A., and Jedrzejas M. J. 2002b. PrfA protein of Bacillus species: Prediction and demonstration of endonuclease activity on DNA. Protein Sci. in press.
91. Rigden, D. J., Bagyan, I., Lamani, E., Setlow, P., and Jedrzejas, M. J. 2001. A cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus is actually a broad specificity phosphatase. Protein Sci. 10:1835-1846.
92. + synthetase structure. Structure 6:1129-1140.
93. + synthetase from Bacillus subtilis. EMBO J. 15:5125-5134.
94. Rossjohn, J., Gilbert, R. J., Crane, D., Morgan, P. J., Mitchell, T. J., Rowe, A. J., Andrew, P. W., Paton, J. C., Tweten, R. K., and Parker, M. W. 1998. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J. Mol. Biol. 284:449-461.
95. Rossjohn, J., S. C. Feil, W. J. McKinstry, R. K. Tweten, and M. W. Parker. 1997. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89:685-692.
96. Rubins, J. B. and Janoff, E. N. 1998. Pneumolysin: A multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:21-27.
97. Sanchez-Salas, J. L., Santiago-Lara, M. L., Setlow, B., Sussman, M. D., and Setlow, P. 1992. Properties of Bacillus megaterium and Bacillus subtilis mutants which lack the protease that degrades small, acid-soluble proteins during spore germination. J. Bacteriol. 174:807-814.
98. Schuch, R., Nelson, D., and Fischetti, V. A. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418:884-889.
99. Sellman, B. R., Mourez, M., and Collier, R. J. 2001. Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax. Science 292:695-697.
100. Setlow, B. and Setlow, P. 1977. Levels of oxidized and reduced pyridine nucleotides in dormant spores and during growth, sporulation, and spore germination of Bacillus megaterium. J. Bacteriol. 129:857-865.
101. Setlow, P. 1991. Changes in forespore chromosome structure during sporulation in Bacillus species. Seminars Dev. Biol. 2:55-62.
102. Setlow, P. 1992. I will survive: Protecting and repairing spore DNA. J. Bacteriol. 174:2737-2741.
103. Setlow, P. 1993a. DNA structure, spore formation and spore properties. In: Regulation of Bacterial Differentiation, Pigot, P. J., Youngman, P., and Moran, C. P., Jr., Eds., pp. 181-194, American Society of Microbiology, Washington, D.C.
104. Setlow, P. 1993b. Mechanisms which contribute to the long-term survival of spores of Bacillus species. J. Appl. Bacteriol. Symp. Suppl. 76:49S-60S.
105. Setlow, P. 1993c. Spore structural properties. In: Bacillus Subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics, Hoch, J. A., Losick, R., and Sonenshein, A. L., Eds., pp. 801-809, American Society of Microbiology, Washington, D.C.
106. Setlow, P. 1995. Mechanism for the prevention of damage to DNA in spores of Bacillus species. Annu. Rev. Microbiol. 49:29-54.
107. Sever, J. L., Brenner, A. I., Gale, A. D., Lyle, J. M., Moulton, L. H., and West, D. J. 2002. Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol. Drug Saf. 11:189-202.
108. Singh, Y., Klimpel, K. R., Arora, N., Sharma, M., and Leppla, S. H. 1994 The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J. Biol. Chem. 269:29039-29046.
109. Slepecky, R. A. 1992. What is Bacillus? In: Biology of Bacilli, Doi, R.H. and McGloughlin, M., Eds., pp. 1-21, Butterworth-Heinemann Press.
110. Smith, L. J. 1995. Enzymes of nucleotide synthesis. Curr. Opin. Struct. Biol., 5:752-757.
111. Song, L., Hobaugh, M. R., Shustak, C., Cheley, S., Bayley, H., and Gouaux, J. E. 1996. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859-1866.
112. Spencer, R. L. and Preiss, J. 1967. Biosynthesis of diphosphopyridine nucleotide. The purification and the properties of diphospyridine nucleotide synthetase from Escherichia coli. J. Biol. Chem. 242:385-392.
113. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., and Kinzler, K. W. 2000. Genes expressed in human tumor endothelium. Science 289:1197-1202.
114. Stanley, J. L. and Smith, H. 1961. Purification of factor I and recognition of a third factor of the anthrax toxin. J. Gen. Microbiol. 26:49-66.
115. Steffen, R., Mellin, J., Woodall, J. P., Rollin, P. E., Lang, R. H., Luth, R., and Waldvogel, A. 1997. Preparation for emergency relief after biological warfare. J. Infect. 34:127-132.
116. Tang, G. and Leppla, S. H. 1999. Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect. Immun. 67:3055-3060.
117. Thorne, C. B. 1993. Bacillus anthracis. In: Bacillus Subtilis and Other Gram-positive Bacteria: Biochemistry, Physiology, and Molecular Genetics, Hoch, J. A., Losick, R., and Sonenshein, A. L., Eds., pp. 113-124, American Society of Microbiology, Washington, D.C.
118. Tranor, K. 2002. IOM deems anthrax vaccine safe, effective but better product needed. Am. J. Health Syst. Pharm. 59:704.
119. Turnbull, P. C. 1991. Anthrax vaccines: Past, present and future. Vaccine 9:533-539.
120. Turnbull, P. C. 2000. Current status of immunization against anthrax: Old vaccines may be here to stay for a while. Curr. Opin. Infect. Dis. 13:113-120.
121. Vitale, G., Bernardi, L., Napolitani, G., Mock, M., and Montecucco, C. 2000. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352:739-745.
122. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
123. Wang, X. M., Wattiez, R., Mock, M., Falmagne, P., Ruysschaert, J. M., and Cabiaux, V. 1997. Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane. Biochemistry 36:14906-14913.
124. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. 1999. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:143-180.
125. Xia, Z. G. and Storm. D. R. 1990. A-type ATP binding consensus sequences are critical for the catalytic activity of the calmodulin-sensitive adenylyl cyclase from Bacillus anthracis. J. Biol. Chem. 265:6517-6520.
126. Zalkin, H. 1985. NAD synthetase. Methods Enzymol. 113:297-302.
127. Zhang, G., Liu, Y., Ruoho, A. E., and Hurley, J. H. 1997. Structure of the adenylyl cyclase catalytic core. Nature 386:247-253.
128. Zhao, J., Milne, J. C., and Collier, R. J. 1995. Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen. J. Biol. Chem. 270:18626-18630.